A decades-old warning rooted in flawed research kept millions of women from life-changing treatment, officials say.
While the new FDA warning is an improvement, CCHR says it does not go far enough to address the well-documented risks of stimulant drugs, and the agency is lagging in updating its warnings. CCHR says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results